Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 23630186)

1.

CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.

Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B, Schendel DJ, Zimmermann W, Pohla H.

Stem Cells. 2013 Aug;31(8):1467-76. doi: 10.1002/stem.1407.

2.

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM.

Mol Cancer. 2006 Nov 3;5:56.

3.

OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.

Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL, Tang L, Zheng LY, He YQ, Li YQ, Wu FQ, Zou SS, Li Z, Wu MC, Feng GS, Wang HY.

J Hepatol. 2012 Sep;57(3):613-20. doi: 10.1016/j.jhep.2012.04.024. Epub 2012 May 19.

PMID:
22612999
4.

Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.

Wang L, Huang T, Chen W, Gao X, Zhou T, Wu Z, Sun Y.

Oncol Rep. 2012 Dec;28(6):2043-8. doi: 10.3892/or.2012.2028. Epub 2012 Sep 12.

PMID:
22972438
5.

Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.

Jung MJ, Rho JK, Kim YM, Jung JE, Jin YB, Ko YG, Lee JS, Lee SJ, Lee JC, Park MJ.

Oncogene. 2013 Jan 10;32(2):209-21. doi: 10.1038/onc.2012.37. Epub 2012 Feb 27.

PMID:
22370645
6.

Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.

Ueda K, Ogasawara S, Akiba J, Nakayama M, Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K, Yano H.

PLoS One. 2013 Oct 8;8(10):e75463. doi: 10.1371/journal.pone.0075463. eCollection 2013.

7.

Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.

Lee HW, Joo KM, Lim JE, Cho HJ, Cho HJ, Park MC, Seol HJ, Seo SI, Lee JI, Kim S, Jeong BC, Nam DH.

Mol Cancer Res. 2013 Nov;11(11):1375-86. doi: 10.1158/1541-7786.MCR-13-0101-T. Epub 2013 Aug 27.

8.
10.

Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.

Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma W, Zhang Y, Li C, Zhang S.

Cancer Lett. 2010 Dec 28;299(2):150-60. doi: 10.1016/j.canlet.2010.08.013. Epub 2010 Sep 16.

PMID:
20846785
11.

The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.

Wu P, Zhang N, Wang X, Zhang C, Li T, Ning X, Gong K.

PLoS One. 2012;7(9):e45122. doi: 10.1371/journal.pone.0045122. Epub 2012 Sep 18.

12.

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Darini CY, Pisani DF, Hofman P, Pedeutour F, Sudaka I, Chomienne C, Dani C, Ladoux A.

Oncogene. 2012 May 10;31(19):2438-49. doi: 10.1038/onc.2011.421. Epub 2011 Sep 19.

PMID:
21927026
13.

Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.

Haviv YS, van Houdt WJ, Lu B, Curiel DT, Zhu ZB.

Mol Cancer Ther. 2004 Jun;3(6):687-91.

14.

The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.

Hu J, Deng X, Bian X, Li G, Tong Y, Li Y, Wang Q, Xin R, He X, Zhou G, Xie P, Li Y, Wang JM, Cao Y.

Clin Cancer Res. 2005 Jul 1;11(13):4658-65.

15.

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

Gatti M, Pattarozzi A, Bajetto A, Würth R, Daga A, Fiaschi P, Zona G, Florio T, Barbieri F.

Toxicology. 2013 Dec 15;314(2-3):209-20. doi: 10.1016/j.tox.2013.10.003. Epub 2013 Oct 21.

PMID:
24157575
16.

Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.

Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.

Int J Oncol. 2012 Sep;41(3):805-17. doi: 10.3892/ijo.2012.1543. Epub 2012 Jul 3.

17.

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma.

Wright TM, Brannon AR, Gordan JD, Mikels AJ, Mitchell C, Chen S, Espinosa I, van de Rijn M, Pruthi R, Wallen E, Edwards L, Nusse R, Rathmell WK.

Oncogene. 2009 Jul 9;28(27):2513-23. doi: 10.1038/onc.2009.116. Epub 2009 May 18.

18.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.

Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J.

Nat Med. 2013 Jan;19(1):50-6. doi: 10.1038/nm.3029. Epub 2012 Dec 9.

19.

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.

Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER.

Cancer Res. 2005 Jun 1;65(11):4598-606.

20.

The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.

Weissinger D, Tagscherer KE, Macher-Göppinger S, Haferkamp A, Wagener N, Roth W.

Mol Cancer. 2013 Oct 10;12(1):120. doi: 10.1186/1476-4598-12-120.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk